Carregant...
AB 84. Pharmacokinetics of moxifloxacin in patients with severe exacerbations of COPD
BACKGROUND: Although moxifloxacin is widely used in patients with COPD exacerbation, its penetration in bronchial secretions has not been evaluated sufficiently. This study aims to investigate pk/pd of moxifloxacin in serum and secretions of patients with severe exacerbations of COPD. PATIENTS AND M...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pioneer Bioscience Publishing Company
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3537350/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s084 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|